» Articles » PMID: 33806413

The Function of Selenium in Central Nervous System: Lessons from MsrB1 Knockout Mouse Models

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Apr 3
PMID 33806413
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

MsrB1 used to be named selenoprotein R, for it was first identified as a selenocysteine containing protein by searching for the selenocysteine insert sequence (SECIS) in the human genome. Later, it was found that MsrB1 is homologous to PilB in , which is a methionine sulfoxide reductase (Msr), specifically reducing L-methionine sulfoxide (L-Met-O) in proteins. In humans and mice, four members constitute the Msr family, which are MsrA, MsrB1, MsrB2, and MsrB3. MsrA can reduce free or protein-containing L-Met-O (), whereas MsrBs can only function on the L-Met-O epimer in proteins. Though there are isomerases existent that could transfer L-Met-O to L-Met-O and vice-versa, the loss of Msr individually results in different phenotypes in mice models. These observations indicate that the function of one Msr cannot be totally complemented by another. Among the mammalian Msrs, MsrB1 is the only selenocysteine-containing protein, and we recently found that loss of MsrB1 perturbs the synaptic plasticity in mice, along with the astrogliosis in their brains. In this review, we summarized the effects resulting from Msr deficiency and the bioactivity of selenium in the central nervous system, especially those that we learned from the MsrB1 knockout mouse model. We hope it will be helpful in better understanding how the trace element selenium participates in the reduction of L-Met-O and becomes involved in neurobiology.

Citing Articles

Development and Optimization of a Redox Enzyme-Based Fluorescence Biosensor for the Identification of MsrB1 Inhibitors.

Shim H, Lee H, Cho H, Jo Y, Tarrago L, Kim H Antioxidants (Basel). 2024; 13(11).

PMID: 39594490 PMC: 11591284. DOI: 10.3390/antiox13111348.


Regulatory Role and Cytoprotective Effects of Exogenous Recombinant SELENOM under Ischemia-like Conditions and Glutamate Excitotoxicity in Cortical Cells In Vitro.

Turovsky E, Plotnikov E, Varlamova E Biomedicines. 2024; 12(8).

PMID: 39200220 PMC: 11351740. DOI: 10.3390/biomedicines12081756.


Selenium Nanoparticles in Protecting the Brain from Stroke: Possible Signaling and Metabolic Mechanisms.

Turovsky E, Baryshev A, Plotnikov E Nanomaterials (Basel). 2024; 14(2).

PMID: 38251125 PMC: 10818530. DOI: 10.3390/nano14020160.

References
1.
Zhang Z, Wu Q, Zheng R, Chen C, Chen Y, Liu Q . Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. J Neurosci. 2017; 37(9):2449-2462. PMC: 6596838. DOI: 10.1523/JNEUROSCI.3229-16.2017. View

2.
Raman A, Pitts M, Seyedali A, Hashimoto A, Seale L, Bellinger F . Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction. Genes Brain Behav. 2012; 11(5):601-13. PMC: 3389215. DOI: 10.1111/j.1601-183X.2012.00794.x. View

3.
Achilli C, Ciana A, Minetti G . The discovery of methionine sulfoxide reductase enzymes: An historical account and future perspectives. Biofactors. 2015; 41(3):135-52. DOI: 10.1002/biof.1214. View

4.
Wizemann T, Moskovitz J, Pearce B, Cundell D, Arvidson C, So M . Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A. 1996; 93(15):7985-90. PMC: 38861. DOI: 10.1073/pnas.93.15.7985. View

5.
Lee S, Lee S, Du J, Jain K, Ding M, Kadado A . Mitochondrial MsrB2 serves as a switch and transducer for mitophagy. EMBO Mol Med. 2019; 11(8):e10409. PMC: 6685081. DOI: 10.15252/emmm.201910409. View